VERVE THERAPEUTICS INC

CUSIP: 92539P101 Class: Common Stock

ROYAL BANK OF CANADA's Holding History (CIK: 0001000275)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 15,615 Value ($000) $176 Avg Close — Range —
Q1 2025
Shares 79,233 Value ($000) $362 Avg Close — Range —
Q4 2024
Shares 79,845 Value ($000) $450 Avg Close — Range —
Q3 2024
Shares 36,514 Value ($000) $176 Avg Close — Range —
Q2 2024
Shares 10,490 Value ($000) $51 Avg Close — Range —
Q1 2024
Shares 17,651 Value ($000) $235 Avg Close — Range —
Q4 2023
Shares 13,451 Value ($000) $187 Avg Close — Range —
Q3 2023
Shares 19,880 Value ($000) $263 Avg Close — Range —
Q2 2023
Shares 17,079 Value ($000) $320 Avg Close — Range —
Q1 2023
Shares 11,223 Value ($000) $161 Avg Close — Range —
Q4 2022
Shares 12,523 Value ($000) $243 Avg Close — Range —
Q3 2022
Shares 7,286 Value ($000) $250 Avg Close — Range —
Q2 2022
Shares 1,131 Value ($000) $17 Avg Close — Range —
Q1 2022
Shares 2,571 Value ($000) $58 Avg Close — Range —
Q4 2021
Shares 7,026 Value ($000) $260 Avg Close — Range —
Q3 2021
Shares 8,860 Value ($000) $416 Avg Close — Range —
Q2 2021
Shares 7,100 Value ($000) $428 Avg Close — Range —